PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Coloplast A/S (COLO-B.CO)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

DK0060448595

Sector

Healthcare

Highlights

Market Cap

DKK 179.53B

EPS (TTM)

DKK 21.72

PE Ratio

36.68

PEG Ratio

2.70

Total Revenue (TTM)

DKK 27.45B

Gross Profit (TTM)

DKK 18.52B

EBITDA (TTM)

DKK 6.46B

Year Range

DKK 772.00 - DKK 952.95

Target Price

DKK 902.50

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
COLO-B.CO vs. NVO COLO-B.CO vs. ABBV
Popular comparisons:
COLO-B.CO vs. NVO COLO-B.CO vs. ABBV

Performance

Performance Chart

The chart shows the growth of an initial investment of DKK 10,000 in Coloplast A/S, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-20.00%-10.00%0.00%10.00%20.00%SeptemberOctoberNovemberDecember2025February
-13.37%
15.18%
COLO-B.CO (Coloplast A/S)
Benchmark (^GSPC)

Returns By Period

Coloplast A/S had a return of 0.97% year-to-date (YTD) and -8.91% in the last 12 months. Over the past 10 years, Coloplast A/S had an annualized return of 7.09%, while the S&P 500 had an annualized return of 11.26%, indicating that Coloplast A/S did not perform as well as the benchmark.


COLO-B.CO

YTD

0.97%

1M

-1.76%

6M

-13.37%

1Y

-8.91%

5Y*

-2.19%

10Y*

7.09%

^GSPC (Benchmark)

YTD

3.96%

1M

1.97%

6M

9.03%

1Y

22.16%

5Y*

12.60%

10Y*

11.26%

*Annualized

Monthly Returns

The table below presents the monthly returns of COLO-B.CO, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20255.57%0.97%
20243.32%14.79%1.83%-9.22%-1.97%1.43%7.17%2.63%-4.91%-2.26%4.00%-9.85%4.47%
20231.31%-1.07%10.81%7.90%-9.38%-2.71%-1.27%-6.79%-4.79%-1.69%9.93%-2.44%-2.40%
2022-16.73%4.15%2.63%-6.39%-13.58%-1.92%5.07%-0.14%-8.54%8.28%-0.76%-0.86%-27.80%
2021-1.31%2.33%1.60%7.31%-5.67%7.12%11.47%-4.88%-7.75%4.22%2.29%8.70%26.10%
20202.98%6.32%9.04%9.16%4.96%-8.62%4.67%-1.63%-5.20%-7.05%-0.13%1.24%14.68%
2019-1.62%9.85%11.69%-1.64%-0.07%4.10%6.26%2.51%2.10%-2.16%-0.74%4.71%39.66%
20187.92%-2.82%-1.35%2.62%16.52%5.39%8.97%-1.09%-4.45%-6.36%2.21%-2.03%25.89%
20173.46%0.39%10.07%7.35%-2.20%-4.06%-0.74%-5.28%-0.10%9.98%-12.79%2.89%6.74%
20160.99%-7.56%-4.58%-1.77%4.77%-1.64%4.88%-2.78%1.28%-8.02%-5.69%9.01%-11.93%
20150.29%2.31%-1.22%3.42%-4.86%-14.41%11.59%-7.53%4.33%2.94%17.76%-1.37%9.87%
201415.63%9.71%-3.71%2.94%5.58%4.32%-4.16%-0.28%4.97%4.66%0.29%1.54%48.08%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of COLO-B.CO is 31, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of COLO-B.CO is 3131
Overall Rank
The Sharpe Ratio Rank of COLO-B.CO is 3333
Sharpe Ratio Rank
The Sortino Ratio Rank of COLO-B.CO is 2626
Sortino Ratio Rank
The Omega Ratio Rank of COLO-B.CO is 2727
Omega Ratio Rank
The Calmar Ratio Rank of COLO-B.CO is 3434
Calmar Ratio Rank
The Martin Ratio Rank of COLO-B.CO is 3535
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Coloplast A/S (COLO-B.CO) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for COLO-B.CO, currently valued at -0.22, compared to the broader market-2.000.002.004.00-0.221.83
The chart of Sortino ratio for COLO-B.CO, currently valued at -0.16, compared to the broader market-6.00-4.00-2.000.002.004.006.00-0.162.47
The chart of Omega ratio for COLO-B.CO, currently valued at 0.98, compared to the broader market0.501.001.502.000.981.33
The chart of Calmar ratio for COLO-B.CO, currently valued at -0.17, compared to the broader market0.002.004.006.00-0.172.76
The chart of Martin ratio for COLO-B.CO, currently valued at -0.47, compared to the broader market-10.000.0010.0020.0030.00-0.4711.27
COLO-B.CO
^GSPC

The current Coloplast A/S Sharpe ratio is -0.22. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Coloplast A/S with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.001.002.003.00SeptemberOctoberNovemberDecember2025February
-0.22
1.95
COLO-B.CO (Coloplast A/S)
Benchmark (^GSPC)

Dividends

Dividend History

Coloplast A/S provided a 2.77% dividend yield over the last twelve months, with an annual payout of DKK 22.00 per share. The company has been increasing its dividends for 34 consecutive years, earning it the status of a dividend aristocrat.


2.00%2.50%3.00%DKK 0.00DKK 5.00DKK 10.00DKK 15.00DKK 20.0020142015201620172018201920202021202220232024
Dividends
Dividend Yield
PeriodTTM20242023202220212020201920182017201620152014
DividendDKK 22.00DKK 22.00DKK 21.00DKK 20.00DKK 19.00DKK 18.00DKK 17.00DKK 16.00DKK 15.00DKK 13.50DKK 12.50DKK 12.00

Dividend yield

2.77%2.80%2.72%2.46%1.65%1.94%2.06%2.64%3.04%2.83%2.24%2.31%

Monthly Dividends

The table displays the monthly dividend distributions for Coloplast A/S. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025DKK 0.00DKK 0.00DKK 0.00
2024DKK 0.00DKK 0.00DKK 0.00DKK 0.00DKK 5.00DKK 0.00DKK 0.00DKK 0.00DKK 0.00DKK 0.00DKK 0.00DKK 17.00DKK 22.00
2023DKK 0.00DKK 0.00DKK 0.00DKK 0.00DKK 5.00DKK 0.00DKK 0.00DKK 0.00DKK 0.00DKK 0.00DKK 0.00DKK 16.00DKK 21.00
2022DKK 0.00DKK 0.00DKK 0.00DKK 0.00DKK 5.00DKK 0.00DKK 0.00DKK 0.00DKK 0.00DKK 0.00DKK 0.00DKK 15.00DKK 20.00
2021DKK 0.00DKK 0.00DKK 0.00DKK 0.00DKK 5.00DKK 0.00DKK 0.00DKK 0.00DKK 0.00DKK 0.00DKK 0.00DKK 14.00DKK 19.00
2020DKK 0.00DKK 0.00DKK 0.00DKK 0.00DKK 5.00DKK 0.00DKK 0.00DKK 0.00DKK 0.00DKK 0.00DKK 0.00DKK 13.00DKK 18.00
2019DKK 0.00DKK 0.00DKK 0.00DKK 0.00DKK 5.00DKK 0.00DKK 0.00DKK 0.00DKK 0.00DKK 0.00DKK 0.00DKK 12.00DKK 17.00
2018DKK 0.00DKK 0.00DKK 0.00DKK 0.00DKK 5.00DKK 0.00DKK 0.00DKK 0.00DKK 0.00DKK 0.00DKK 0.00DKK 11.00DKK 16.00
2017DKK 0.00DKK 0.00DKK 0.00DKK 0.00DKK 4.50DKK 0.00DKK 0.00DKK 0.00DKK 0.00DKK 0.00DKK 0.00DKK 10.50DKK 15.00
2016DKK 0.00DKK 0.00DKK 0.00DKK 0.00DKK 4.50DKK 0.00DKK 0.00DKK 0.00DKK 0.00DKK 0.00DKK 0.00DKK 9.00DKK 13.50
2015DKK 0.00DKK 0.00DKK 0.00DKK 0.00DKK 4.50DKK 0.00DKK 0.00DKK 0.00DKK 0.00DKK 0.00DKK 0.00DKK 8.00DKK 12.50
2014DKK 4.50DKK 0.00DKK 0.00DKK 0.00DKK 0.00DKK 0.00DKK 0.00DKK 7.50DKK 12.00

Dividend Yield & Payout


Dividend Yield
100.0%200.0%300.0%400.0%500.0%600.0%2.8%
Coloplast A/S has a dividend yield of 2.77%, which is quite average when compared to the overall market.
Payout Ratio
200.0%400.0%600.0%800.0%1,000.0%93.8%
Coloplast A/S has a payout ratio of 93.82%, which is above the market average. This might signify the company's strong earnings or financial health. However, it could also hint at a more mature business phase with potentially slower growth.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%0.00%SeptemberOctoberNovemberDecember2025February
-26.84%
-0.96%
COLO-B.CO (Coloplast A/S)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Coloplast A/S. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Coloplast A/S was 43.67%, occurring on Oct 27, 1994. Recovery took 323 trading sessions.

The current Coloplast A/S drawdown is 26.84%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-43.67%Mar 11, 1994149Oct 27, 1994323Feb 7, 1996472
-40.5%Oct 12, 2007204Aug 8, 2008367Jan 28, 2010571
-38.64%Dec 30, 2021470Nov 10, 2023
-33.55%Jul 9, 2002167Mar 5, 2003521Apr 5, 2005688
-25.1%Dec 29, 1998300Mar 8, 2000104Aug 10, 2000404

Volatility

Volatility Chart

The current Coloplast A/S volatility is 5.19%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


3.00%4.00%5.00%6.00%7.00%8.00%9.00%SeptemberOctoberNovemberDecember2025February
5.19%
3.49%
COLO-B.CO (Coloplast A/S)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Coloplast A/S over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Valuation

The Valuation section provides an assessment of the market value of Coloplast A/S compared to its peers in the Medical Instruments & Supplies industry.


PE Ratio
50.0100.0150.0200.036.7
The chart displays the price to earnings (P/E) ratio for COLO-B.CO in comparison to other companies of the Medical Instruments & Supplies industry. Currently, COLO-B.CO has a PE value of 36.7. This PE ratio falls in the average range for the industry.
PEG Ratio
0.05.010.015.020.02.7
The chart displays the price to earnings to growth (PEG) ratio for COLO-B.CO in comparison to other companies of the Medical Instruments & Supplies industry. Currently, COLO-B.CO has a PEG value of 2.7. This PEG ratio is much higher than those of other companies of the industry. This might be an indicator of the company being overvalued.

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Coloplast A/S.


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab